4 studies found for:    18212285 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting mWELLCARE:An Integrated mHealth System for the Prevention and Care of Chronic Disease
Conditions: Hypertension;   Diabetes;   Depression;   Alcohol Abuse
Interventions: Other: mWELLCARE;   Other: Usual Care
2 Withdrawn Cardiovascular Risk Following Conversion to Full Dose Myfortic® and Neoral® Two-hour Post Level Monitoring
Conditions: Cardiovascular Disease;   Cardiovascular Outcomes;   Kidney Transplant Recipients;   Kidney Transplantation
Interventions: Drug: Myfortic®;   Drug: Neoral®;   Drug: Cellcept®;   Drug: Prednisone
3 Completed Improving Care for Patients With High Blood Pressure
Conditions: Hypertension;   Cardiovascular Disease Risk
Intervention: Behavioral: Complex quality improvement intervention
4 Completed
Has Results
A Study to Assess the Efficacy of Raltegravir (Isentress®), Administered in Combination With Other Antiretroviral Drugs as Treatment for Adults and Older Adults Infected With the Human Immunodeficiency Virus 1 (HIV-1)(MK-0518-145) (Wirksamkeit Von Isentress® Unter Praxisbedingungen)
Condition: HIV-1 Infection
Intervention: Drug: Raltegravir

Indicates status has not been verified in more than two years